Transforming India’s Clinical Research Landscape: Business Implications of the New Drugs and Clinical Trials (Amendment) Rules, 2024
Introduction India has long been recognized as a global destination for clinical research and drug development, owing to its large and diverse patient pool, cost-effective operations, and strong scientific talent. The government has recently taken a bold step to further enhance this position by introducing the New Drugs and Clinical Trials (Amendment) Rules, 2024 (“NDCT […]